Contrafect Corp (CFRX)

[noretreat]

And here is thing number 2> (which means NOW a good time to take a position)

ContraFect Seeks to Raise $40 Mln in Underwritten Public Offering of Shares, Warrants
MIDNIGHT TRADER 8:32 AM ET 7/20/2017

09:32 AM EDT, 07/20/2017 (MT Newswires) -- ContraFect(CFRX) , a biotechnology company, said on Thursday it aims to raise $40 million from an underwritten public offering of shares and warrants, which it priced at $1.25 per share and warrant.

The company is selling 32 million shares of its common stock and related warrants, which enable the holder to buy 16 million shares with an exercise price of $1.55 per share.

The offering is expected to close on or about July 25.

Piper Jaffray is the sole book-running manager and William Blair & Co. is the lead manager.

The shares lost nearly 14% shortly after the market's open Thursday.

Price: 1.25, Change: -0.20, Percent Change: -13.79

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.